The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•4 May 2026•

1 min read

Green Thumb Industries Files for DEA Registration After Cannabis Rescheduling

Key Facts

1Green Thumb Industries submitted applications to the U.S. DEA to register state-licensed medical cannabis operations.

2The action follows the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.

Green Thumb Industries Inc. has officially submitted applications to the U.S. Drug Enforcement Administration (DEA) to register its state-licensed medical cannabis operations. This strategic move follows the historic federal rescheduling of medical marijuana to Schedule III under the Controlled Substances Act. By utilizing an expedited pathway, the company aims to formalize its federal status in alignment with the new regulatory landscape. The shift to Schedule III is expected to reduce federal restrictions, potentially offering the company significant benefits in tax treatment and improved banking access. CEO Ben Kovler highlighted that this filing is a pivotal step in integrating the cannabis industry into the broader legal commercial framework. This development marks a critical operational execution of the recent policy changes, signaling a positive milestone for major cannabis operators in the United States.